Hyman Muss

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

F. Holmes, J. O’Shaughnessy, J. Pippen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

Timothy Hunter, Scott Tighe, Jeffrey Bond, 2009, Breast Cancer Research and Treatment.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Larry Norton, Donald A Berry, Edith A Perez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.

Lyndsay Harris, Donald Berry, Larry Norton, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accuracy of screening mammography in older women.

Benjamin Littenberg, Natalie Sinclair, B. Littenberg, 2011, AJR. American journal of roentgenology.

Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study

Karen Plaut, Donald Weaver, D. Weaver, 2008, Breast Cancer Research and Treatment.

End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.

Murielle Mauer, Supriya G Mohile, Giuseppe Curigliano, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.